Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Islet Studies

Cx36-Mediated Coupling Reduces β-Cell Heterogeneity, Confines the Stimulating Glucose Concentration Range, and Affects Insulin Release Kinetics

  1. Stephan Speier1,
  2. Asllan Gjinovci2,
  3. Anne Charollais2,
  4. Paolo Meda2 and
  5. Marjan Rupnik1
  1. 1Neuroendocrinology, European Neuroscience Institute Göttingen, Göttingen, Germany
  2. 2Department of Cell Physiology and Metabolism, University of Geneva, Genève, Switzerland
  1. Address correspondence and reprint requests to Stephan Speier, The Rolf Luft Center for Diabetes Research, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital L1, Stockholm, Sweden. E-mail: stephan.speier{at}ki.se
Diabetes 2007 Apr; 56(4): 1078-1086. https://doi.org/10.2337/db06-0232
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Article Figures & Tables

Figures

  • Tables
  • FIG. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Residual whole-cell conductance and KATP-channel density of β-cells from NMRI, Cx36+/+, Cx36+/−, and Cx36−/− mice (latter three mice have a C57Bl/6 background). A: Representative traces of current responses to a voltage ramp, after KATP-channel closure by 5 mmol/l intracellular ATP and extracellular application of 100 μmol/l tolbutamide. B: Statistics of the residual conductance measured as the slope of the current response between −100 and −60 mV. C: Maximal KATP-channel conductance after dialysis in the absence of ATP. *P < 0.05, **P < 0.05 vs. value of Cx36+/+ mice.

  • FIG. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 2.

    A: Current-voltage relation of Ca2+ channels (n = 11–13) of β-cells from NMRI, Cx36+/+, Cx36+/−, and Cx36−/− mice (latter three on a C57Bl/6 background). B: Representative traces of Ca2+ currents of β-cells from Cx36+/+, Cx36+/−, and Cx36−/− mice in response to a voltage step depolarization to −10 mV from a holding potential of −70 mV. *Significant differences (P < 0.05).

  • FIG. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 3.

    K+ currents in coupled and noncoupled β-cells. A: Representative current traces of Cx36+/+ and Cx36−/− β-cells in response to step depolarizations between −50 and +50 mV from a holding potential of −150 mV. B: Current-voltage relationship of peak outward current in β-cells from Cx36+/+, Cx36+/−, and Cx36−/− mice.

  • FIG. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 4.

    Excitability of β-cells of Cx36+/+ mice. A: Membrane potential (top trace) and whole-cell conductance (bottom trace) as a result of intracellular dialysis of 5 mmol/l ATP and extracellular application of 100 μmol/l tolbutamide. Gaps in the recording indicate application of voltage protocols to assess channel properties. B: Currents recorded at −50 mV (bottom trace) during electrical activity (top trace).

  • FIG. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 5.

    Excitability of β-cells of Cx36+/− mice. A: Membrane potential (top trace) and whole-cell conductance (bottom trace) as a result of intracellular dialysis of 5 mmol/l ATP and extracellular application of 100 μmol/l tolbutamide. B: Currents recorded at −50 mV (bottom trace) during electrical activity (top trace).

  • FIG. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 6.

    Excitability of β-cells of Cx36−/− mice. A: Membrane potential (top trace) and whole-cell conductance (bottom trace) as a result of intracellular dialysis of 5 mmol/l ATP and extracellular application of 100 μmol/l tolbutamide. Inset: Closure of KATP channels by dialysis of 5 mmol/l ATP in β-cells of wild-type Cx36+/+ and Cx36−/− mice in two experiments with comparable series resistance. B: Currents recorded at −50 mV (bottom trace) during electrical activity (top trace).

  • FIG. 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 7.

    Membrane potential changes after dialysis of 5 mmol/l ATP in a β-cell from Cx36+/+ mice, after preincubation of the tissue slice in 13 mmol/l glucose for 7 min.

  • FIG. 8.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 8.

    Double patch-clamp experiment on two coupled β-cells within an islet of Langerhans of a Cx36+/+ mouse. Electrical activity was induced by dialysis of both cells with 5 mmol/l ATP and perfusion of the tissue slice with 100 μmol/l tolbutamide. A: Membrane potential recording of one β-cell and its dependence on the membrane potential of the coupled β-cell. The coupled β-cell was clamped to the membrane potentials indicated on top of the graph. B: Average spike amplitude at different clamping voltages. *P < 0.001.

  • FIG. 9.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIG. 9.

    Return of high glucose–stimulated insulin release to basal levels in perfused pancreas of wild-type and Cx36-deficient mice. Pancreata of Cx36+/+ (open circles, n = 9) and Cx36+/− mice (gray solid circles, n = 10) showed an exponential decay of insulin output when glucose was switched from 16.4 to 1.4 mmol/l. In contrast, the decay in pancreata of Cx36 (−/−) mice (black solid circles, n = 10) was much more slow. Data are mean ± SE of four to five animals in each group.

Tables

  • Figures
  • TABLE 1

    Spiking characteristics of β-cells from Cx36+/+, Cx36+/−, and Cx36−/− mice

    nMean spiking frequency (Hz)Spike amplitude (mV)
    MeanMaximal
    Cx36+/+85.5 ± 0.817.1 ± 0.824.7 ± 1.3
    Cx36+/−55.2 ± 0.816.0 ± 1.622.0 ± 1.5
    Cx36−/−115.3 ± 0.527.3 ± 1.7*40.9 ± 2.3†
    • Data are mean ± SE.

    • *

      * P < 0.002.

    • †

      † P < 0.001.

PreviousNext
Back to top

In this Issue

April 2007, 56(4)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cx36-Mediated Coupling Reduces β-Cell Heterogeneity, Confines the Stimulating Glucose Concentration Range, and Affects Insulin Release Kinetics
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cx36-Mediated Coupling Reduces β-Cell Heterogeneity, Confines the Stimulating Glucose Concentration Range, and Affects Insulin Release Kinetics
Stephan Speier, Asllan Gjinovci, Anne Charollais, Paolo Meda, Marjan Rupnik
Diabetes Apr 2007, 56 (4) 1078-1086; DOI: 10.2337/db06-0232

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Cx36-Mediated Coupling Reduces β-Cell Heterogeneity, Confines the Stimulating Glucose Concentration Range, and Affects Insulin Release Kinetics
Stephan Speier, Asllan Gjinovci, Anne Charollais, Paolo Meda, Marjan Rupnik
Diabetes Apr 2007, 56 (4) 1078-1086; DOI: 10.2337/db06-0232
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
  • Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with KATP Channels
  • Pancreatic β-Cell–Specific Deletion of VPS41 Causes Diabetes Due to Defects in Insulin Secretion
Show more Islet Studies

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.